VALIDATION IMAGES
Lane 1: Human placenta; Lane 2: JAR; Lane 3: Human liver lysate; Probed with LAMP2a (2C4 ) Monoclonal Antibody (bsm-52255R) at 1:1000 overnight at 4°C followed by a conjugated secondary antibody for 60 minutes at 37°C.
Paraformaldehyde-fixed and paraffin-embedded Human liver tissue incubated with LAMP2a (2C4) Monoclonal Antibody (bsm-52255R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human kidney tissue incubated with LAMP2a (2C4) Monoclonal Antibody (bsm-52255R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human pancreas tissue incubated with LAMP2a (2C4) Monoclonal Antibody (bsm-52255R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse placenta tissue incubated with LAMP2a (2C4) Monoclonal Antibody (bsm-52255R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse kidney tissue incubated with LAMP2a (2C4) Monoclonal Antibody (bsm-52255R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse pancreas tissue incubated with LAMP2a (2C4) Monoclonal Antibody (bsm-52255R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.